Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01641809
Brief Title: Dose Ranging Study of GSK1265744 Plus Nucleoside Reverse Transcriptase Inhibitors for Induction of Human Immunodeficiency Virus-1 (HIV-1) Virologic Suppression Followed by Virologic Suppression Maintenance by GSK1265744 Plus Rilpivirine

First Submitted : June 28, 2012
First Submitted that Met QC Criteria : July 12, 2012
First Posted : July 17, 2012 (Estimate)

Results First Submitted : January 21, 2020
Results First Submitted that Met QC Criteria : January 21, 2020
Results First Posted : January 30, 2020

Certification/Extension First Submitted : March 13, 2014
Certification/Extension First Submitted that Met QC Criteria : March 13, 2014
Certification/Extension First Posted : April 11, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : January 21, 2020
Last Update Posted : January 30, 2020